SCHEMBL48607

SCHEMBL48607

O=Cc1ccc(F)c(F)c1

nearest known ligand 0.52

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
NFE2L2 Q16236 2/20 0.50
KDM4E B2RXH2 1/20 0.46
PTGS2 P35354 1/20 0.46
RAB9A P51151 1/20 0.46
HSD17B10 Q99714 2/20 0.46
KIF11 P52732 1/20 0.42
PLA2G7 Q13093 2/20 0.42
TSHR P16473 1/20 0.41
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
CYP2A6 P11509 3/20 0.40
TDP1 Q9NUW8 1/20 0.40
ALDH5A1 P51649 1/20 0.40
ABAT P80404 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29389102 1.00 ALDH1A1 (0.52) ALDH1A1SMN1; SMN2NFE2L2KDM4EPTGS2
SCHEMBL4808094 0.97 ALDH1A1 (0.50) ALDH1A1SMN1; SMN2NFE2L2KDM4EPTGS2
Hydrazine SCHEMBL27687525 0.95 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2NFE2L2KDM4EPTGS2
Methylene Chloride SCHEMBL27781503 0.91 ALDH1A1 (0.46) ALDH1A1SMN1; SMN2NFE2L2KDM4EPTGS2
Ethylene Glycol SCHEMBL28725409 0.89 ALDH1A1 (0.44) ALDH1A1SMN1; SMN2NFE2L2KDM4EPTGS2
SCHEMBL18002551 0.85 NFE2L2 (0.67) ALDH1A1SMN1; SMN2NFE2L2PTGS2RAB9A
Benzidine SCHEMBL6692243 0.84 KIF11 (0.45) ALDH1A1SMN1; SMN2NFE2L2KDM4EPTGS2
Acrylic Acid SCHEMBL28129825 0.84 PLA2G7 (0.42) ALDH1A1SMN1; SMN2NFE2L2KDM4EPTGS2
SCHEMBL3430702 0.84 NFE2L2 (0.52) ALDH1A1SMN1; SMN2NFE2L2KDM4EPLA2G7
3-Hydroxybenzaldehyde SCHEMBL7545336 0.82 CCNB2 (0.49) ALDH1A1NFE2L2KDM4EPTGS2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 2948 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4205741-B1 CYP2E1 INHIBITORS FOR THE TREATMENT OF INFLAMMATORY-MEDIATED DISEASES SUZHOU LINGXI BIOTECHNOLOGY CO LTD (CN) 2025-12-10 EP claimed
US-20250122202-A1 EGFR INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF SHANDONG NEW TIME PHARMACEUTICAL CO., LTD. (CN) 2025-04-17 US claimed
EP-4403556-A1 EGFR INHIBITOR, PREPARATION METHOD THEREFOR AND USE THEREOF Shandong New Time Pharmaceutical Co., Ltd. (CN) 2024-07-24 EP claimed
CN-115160300-B Coumarin compound, preparation method thereof and application of coumarin compound in resisting Alzheimer disease 中国人民解放军北部战区总医院 2024-05-31 CN claimed
CN-118103371-A EGFR inhibitor and preparation method and application thereof 山东新时代药业有限公司 2024-05-28 CN claimed
CN-114409595-B 1-Styryl isoquinoline derivative and preparation and application thereof 南华大学附属第一医院 2024-05-14 CN claimed
CN-117865959-A 2- (4-fluoro) -phenyl-6-cyclopropyl-5, 6,7, 8-tetrahydropyrido pyrimidine derivative and synthesis and application thereof 西华大学 2024-04-12 CN claimed
CN-117865957-A 2-phenyl-4-phenyl-6-N-isopropyl substituted pyrimidopyridine derivative and synthesis and application thereof 西华大学 2024-04-12 CN claimed
CN-117865958-A 4-phenyl-8 styryl substituted pyrimidopyridine benzamide compound and synthesis and application thereof 西华大学 2024-04-12 CN claimed
CN-115043737-B Tetrahydrolinalool secondary amine compound, preparation method and weeding application thereof 中国林业科学研究院林产化学工业研究所 2024-03-15 CN claimed
WO-2001019808-A1 CHEMICAL COMPOUNDS AND COMPOSITIONS AND THEIR USE AS CATHEPSIN S INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2001-03-22 WO claimed
WO-2001019796-A1 COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS AS CATHEPSIN S INHIBITORS AXYS PHARMACEUTICALS, INC. (US) 2001-03-22 WO claimed
EP-0983507-A1 TRICYCLIC TETRAHYDROQUINOLINE DERIVATIVES AND TRICYCLIC TETRAHYDROQUINOLINE COMBINATORIAL LIBRARIES Trega Biosciences, Inc. (US) 2000-03-08 EP claimed
EP-0977989-A1 4-SUBSTITUTED-QUINOLINE DERIVATIVES AND 4-SUBSTITUTE-QUINOLINE COMBINATORIAL LIBRARIES TREGA BIOSCIENCES, INC. (US) 2000-02-09 EP claimed
WO-1998034115-A1 4-SUBSTITUTED-QUINOLINE DERIVATIVES AND 4-SUBSTITUTE-QUINOLINE COMBINATORIAL LIBRARIES TREGA BIOSCIENCES, INC. (US) 1998-08-06 WO claimed
WO-1998034111-A1 TRICYCLIC TETRAHYDROQUINOLINE DERIVATIVES AND TRICYCLIC TETRAHYDROQUINOLINE COMBINATORIAL LIBRARIES TREGA BIOSCIENCES, INC. (US) 1998-08-06 WO claimed
EP-0653412-B1 Process for preparing 4,5-difluorobenzaldehydes BAYER AG (DE) 1998-01-21 EP claimed
EP-0539274-B1 Method for the synthesis of aldehydes and of their derivatives RHONE POULENC CHIMIE (FR) 1996-04-10 EP claimed
US-5489715-A Process for preparing 4,5-difluorobenzaldehydes BAYER AKTIENGESELLSCHAFT (DE) 1996-02-06 US claimed
US-5334769-A By vapor phase reduction of acids, esters or anhydrides; bimetallic ruthenium-tin catalyst RHONE-POULENC CHIMIE (FR) 1994-08-02 US claimed